Countagen AB
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$1.13M
Company Overview
Countagen AB is a biotechnology company that develops gene editing analysis tools and provides genomic safety validation services for cell and gene therapy development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Countagen AB Comparables
Compare Countagen AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| COBO Technologies | 84% | |
| CRISPR QC | 83% | |
| Broken String Biosciences | 83% | |
Countagen AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Seed | Jun 27, 2022 |
Countagen AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Seed |
| Vinnova | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 48% MoM, reaching 3.4K.
- Nov 7, 2023
Grew 38% QoQ, from 8 to 11 employees.
Countagen AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Countagen AB's valuation, stock price, and market status.